1 / 127

Paramedic Care: Principles & Practice Volume 1 Introduction to Advanced Prehospital Care

Paramedic Care: Principles & Practice Volume 1 Introduction to Advanced Prehospital Care. Chapter 9 General Principles of Pharmacology. Chapter 9, Part 2 Drug Classifications. Part 2 Topics . Classifying Drugs Drugs Used to Affect the Nervous System

Télécharger la présentation

Paramedic Care: Principles & Practice Volume 1 Introduction to Advanced Prehospital Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Paramedic Care:Principles & Practice Volume 1Introduction to Advanced Prehospital Care

  2. Chapter 9 General Principles of Pharmacology

  3. Chapter 9, Part 2Drug Classifications

  4. Part 2 Topics • Classifying Drugs • Drugs Used to Affect the Nervous System • Drugs Used to Affect the Cardiovascular System • Drugs Used to Affect the Respiratory System • Drugs Used to Affect the Gastrointestinal System • Drugs Used to Affect the Eyes • Drugs Used to Affect the Ears • Drugs Used to Affect the Endocrine System • Drugs Used to Treat Cancer • Drugs Used to Treat Infectious Diseases and Inflammation • Drugs Used to Affect the Skin • Drugs Used to Supplement the Diet • Drugs Used to Treat Poisoning and Overdoses

  5. Classifying Drugs

  6. Classifying Drugs • Drugs can be classified many ways: • Body system they affect • Mechanism of action • Indications • Source or by chemical class • A prototype best demonstrates the class’s common properties and illustrates its particular characteristics.

  7. Drugs Used to Affect the Nervous System

  8. Nervous System • Two major divisions • Central Nervous System • Brain and spinal cord • Peripheral nervous system • Outside of CNS

  9. Analgesics and antagonists Anesthetics Anti-anxiety and sedative-hypnotic drugs Antiseizure or anti-epileptic drugs Central nervous system stimulants Psychotherapeutic medications Parkinson’s medications Central Nervous System Medications

  10. Central Nervous System Medications • Analgesics and Antagonists • Analgesia is removal of pain • Two basic subclasses of analgesics • Opioid • Morphine is prototype • Nonopioid • Affects the production of prostaglandins and cyclooxygenase

  11. Central Nervous System Medications • Analgesics and Antagonists (cont.) • Opioid antagonists • Competitively binds with opioid receptors • Naloxone is prototype • Adjunct medications • Enhancement of effect • Diazepam, lorazepam, phenergan • Agonist-Antagonist • Talwin, Stadol, and Nubain

  12. Central Nervous System Medications • Anesthetics • Induces a state of anesthesia, or loss of sensation to touch or pain • As a group tend to cause respiratory, central nervous system (CNS), and cardiovascular depression • Given either by inhalation or injection • Paramedics primarily use these agents to assist with intubation in rapid sequence intubation

  13. Central Nervous System Medications • Antianxiety and Sedative-Hypnotic Drugs • Used to decrease anxiety, induce amnesia, and assist sleeping and as part of a balanced approach to anesthesia • Sedation • Hypnosis • Two main pharmacologic classes are benzodiazepines and barbiturates

  14. Central Nervous System Medications • Antianxiety and Sedative-Hypnotic Drugs • Benzodiazepines • Relatively safe and effective for treating general anxiety and insomnia • Hyperpolarize the membrane of CNS neurons • Benzodiazepines only increase the effectiveness of GABA, therefore, the amount of GABA present limits their effects • Flumazenil is available as antidote

  15. Central Nervous System Medications • Antiseizure or Antiepileptic Drugs • Seizures are treated through several general mechanisms • Direct action on the sodium and calcium ion channels in the neural membranes • Dilantin inhibits inflow of sodium • Interact with the GABA receptor-chloride ion channel complex • Classes include benzodiazepines, barbiturates, hydantoins, succinimides, and miscellaneous medications such as valproic acid

  16. Benzodiazepine Receptors

  17. Central Nervous System Medications • Central Nervous System Stimulants • Two techniques may accomplish this: • Increasing the release or effectiveness of excitatory neurotransmitters • Decreasing the release or effectiveness of inhibitory neurotransmitters • Three pharmacologic classes: amphetamines, methylphenidates, and methylxanthines

  18. Central Nervous System Medications • Central Nervous System Stimulants • Amphetamines • Most common uses are treating drowsiness and fatigue and suppressing the appetite • Methylphenidate • Commonly prescribed drug for attention deficit hyperactivity disorder (ADHD) • Methylxanthines • Caffeine, aminophylline, and theophylline

  19. Central Nervous System Medications • Psychotherapeutic Medications • Treat mental dysfunction • Pathologies, seem to involve the monoamine neurotransmitters • Norepinephrine, dopamine, serotonin • Implicated in the control and regulation of emotions • Extrapyramidal symptoms are common side effects of antipsychotic medications

  20. Central Nervous System Medications • Psychotherapeutic Medications • The two chief pharmaceutical classes are phenothiazines and butyrophenones. • Therapeutic effects appear to come from blocking the dopamine receptors. • Chlorpromazine (Thorazine) is the prototype phenothiazine. • Haloperidol (Haldol) is the prototype of the butyrophenones.

  21. Central Nervous System Medications • Psychotherapeutic Medications • Antidepressants • Pharmaceutical interventions for this disease appear to increase the number of neurotransmitters released in the brain. • Tricyclic Anti-depressants • Act by blocking the reuptake of norepinephrine and serotonin • Selective serotonin reuptake inhibitors (SSRIs) • Selectively block the reuptake of serotonin

  22. Tricyclic Antidepressants

  23. SSRI Antidepressants

  24. Central Nervous System Medications • Psychotherapeutic Medications • Monoamine oxidase inhibitors (MAOIs) • MAOIs inhibit monoamine oxidase and block the monoamines’ breakdown, thus increasing their availability. • MAOIs are not commonly used anymore. • The prototype of this class is phenelzine (Nardil).

  25. Monoamine Oxidase Inhibitors

  26. Central Nervous System Medications • Drugs Used to Treat Parkinson’s Disease • Caused by the destruction of dopamine-releasing neurons • Characterized by dyskinesia • Pharmacologic therapy for Parkinson’s disease seeks to restore the balance of dopamine and acetylcholine.

  27. Central Nervous System Medications • Drugs Used to Treat Parkinson’s Disease • Levadopa and Sinemet • Given concomitantly • Amantadine • Promotes the release of dopamine from those dopamine-releasing neurons that remain unaffected by the disease • Anticholinergic drugs • Prototype anticholinergic medication is benztropine (Cogentin)

  28. Autonomic Nervous System • Two functional divisions of the autonomic nervous system • Sympathetic • Fight or flight • Responds to stress • Parasympathetic • Controls vegetative functions such as digestion of food • Work in constant opposition to control organ responses

  29. Autonomic Nervous System • Nerves of the autonomic nervous system exit the central nervous system. • Autonomic Ganglia • Preganglionic nerves • Postganglionic nerves Sympathetic Branch of the Autonomic Nervous System

  30. Autonomic Nervous System • Synapse • No physical connection • Neurotransmitters • Acetylcholine • Norepinephrine

  31. Nervous System Synapse Click here to view an animation on synapses.

  32. Autonomic Nervous System Medications • Drugs affecting the parasympathetic system: • Cholinergics • Anticholinergics • Ganglionic blocking agents • Neuromuscular blocking agents • Ganglionic stimulating agents

  33. Parasympathetic NS Drugs • Stimulation of the parasympathetic nervous system results in the following conditions: • Pupillary constriction • Secretion by digestive glands • Reduction in heart rate and cardiac contractile force • Bronchoconstriction • Increased smooth muscle activity along the digestive tract

  34. Parasympathetic NS Drugs • Acetylcholine (ACh) • Two main types of ACh receptors • Nicotinic • Muscarinic • “Cholinergic” receptors • Cholinergics (parasympathomimetics) • Cholinergic blockers (parasympatholytics)

  35. Parasympathetic NS Drugs • Cholinergics • Act either directly or indirectly • Direct-acting bind with ACh receptor sites • SLUDGE • Bethanechol (Urecholine) • Indirect-acting cholinergic drugs affect acetylcholinesterase • Neostigmine • Physostigmine

  36. Parasympathetic NS Drugs • Anticholinergics • Muscarinic cholinergic antagonists • Competitively bind with muscarinic receptors without stimulating them • Prototype is Atropine • Nicotinic cholinergic antagonists • Block acetylcholine only at nicotinic sites • Ganglionic Blocking Agents •  Trimethaphan (Arfonad) and mecamylamine (Inversine)

  37. Parasympathetic NS Drugs • Neuromuscular Blockers • Produces a state of paralysis without affecting consciousness • By competitive antagonism of nicotinic receptors at the neuromuscular junction • Either depolarizing or non-depolarizing agents • Succinylcholine (Anectine), a depolarizing agent, is commonly used

  38. Parasympathetic NS Drugs • Ganglionic Stimulating Agents • Receptors reside at the ganglia of both the parasympathetic and sympathetic nervous systems. • Nicotine stimulates receptors. • Although, no medical use, it has helped understand the autonomic NS receptors • Causes sympathetic and parasympathetic response

  39. Autonomic Nervous System Medications • Drugs Affecting the Sympathetic Nervous System • Adrenergic receptors • Adrenergic agonists • Adrenergic antagonists • Skeletal muscle relaxants

  40. Sympathetic NS Drugs • Arises from the thoracic and lumbar regions of the spinal cord • Sympathetic ganglia • Chain ganglia • Collateral ganglia

  41. Sympathetic NS Drugs • Adrenergic Receptors • Alpha Receptors • Beta Receptors • Sympathomimetics • Sympatholytics

  42. Sympathetic NS Drugs • Adrenergic Agonists • Direct-acting agents • Indirect-acting agents • Adrenergic agents are chemically and functionally similar to the endogenous neurotransmitters • Norepinephrine, epinephrine, and dopamine • Dobutamine and isoproterenol

  43. Sympathetic NS Drugs • Adrenergic Antagonists (cont.) • Adrenergic antagonists are remarkably selective in which receptor they affect • Alpha adrenergic antagonists • Phenoxybenzamine (Dibenzyline), prazosin (Minipress) • Beta adrenergic antagonists • Propranolol (Inderal), metoprolol (Lopressor), Atenolol (Tenormin)

  44. Sympathetic NS Drugs • Skeletal Muscle Relaxants • Used to treat muscle spasm • Injury and disease causes • Prototype centrally acting skeletal muscle relaxant is baclofen (Lioresal) • Treats spasticity • Cyclobenzaprine (Flexeril) and carisoprodol (Soma) are commonly used for muscle spasms.

  45. Drugs Used to Affect the Cardiovascular System

  46. Review of A and P • Two-sided pump • 4 chambers • Systemic circulation • Pulmonary circulation

  47. Cardiac Conduction System • Specialized cardiac tissue that generates electrical impulses • Conducts them rapidly throughout the heart • Automaticity

  48. Action Potential of Cardiac Pacing Cells • Cyclic activity in the fast potentials has five phases • The slow potentials • Located in the dominant pacemakers • They depolarize differently • Result in self-depolarizing of SA and AV node

  49. Dysrhythmia Generation • Result from either abnormal impulse formation (automaticity) or abnormal conductivity • Tachycardia and bradycardia are most common • An imbalance between the sympathetic and parasympathetic nervous systems

More Related